A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs ...

Texas MS150 is gearing up to celebrate its 40th anniversary as thousands of cyclists raise millions of dollars for the fight ...

Awareness about a disease in at risk-population improve outcomes. That's the simple idea behind a new, bilingual resource for both patients, medical students, and providers to help them overcome ...

(Reuters) -Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple ...

Happening at 9 a.m. on April 27, a walk to raise funds for the National Multiple Sclerosis Society is happening at Capaha ...

DENVER -- An oral suspension of clean-surfaced gold nanocrystals known as CNM-Au8 was safe and well-tolerated in patients ...

Biogen reported first-quarter adjusted EPS of $3.67, up 8%, beating the consensus of $3.44. The company reported sales of ...

The ClearBridge Global Value Improvers Strategy outperformed its MSCI World Value Index benchmark during Q1 2024. Click here ...

Investors and analysts are so used to bad news from Biogen (BIIB) that they seemingly didn’t know how to react when the ...

TG Therapeutics has strong barriers to entry and patent protection for BRIUMVI, allowing for potential growth in '24 and '25.

“Through their Multiple Sclerosis Centers of Excellence, the VA is dedicated to maximizing the quality of life for veterans suffering from MS, and we are thrilled to partner with Lovell to expand the ...

Sanofi reported on Thursday that its first-quarter operating income declined 14.7%, as unfavourable currency effects and ...